Research graph
References from Genome-scale integration of transcriptome and metabolome unveils squalene synthase and dihydrofolate reductase as targets against AML cells resistant to chemotherapy. Local targets link to admitted publications; unresolved targets remain external evidence.
The role and mechanisms of action of microRNAs in cancer drug resistance
2019 · External reference
Can we forecast induction failure in acute myeloid leukemia?
10.3324/haematol.2018.187575 · 2018 · External reference
Unresolved reference
External reference
10.3390/ijms21228505
10.3390/ijms21228505 · External reference
The influence of metabolism on drug response in cancer
2018 · External reference
10.1038/cddis.2013.60
10.1038/cddis.2013.60 · External reference
10.3390/metabo5040571
10.3390/metabo5040571 · External reference
De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition
10.15252/msb.20167321 · 2017 · External reference
10.1016/j.ymben.2016.10.022
10.1016/j.ymben.2016.10.022 · External reference
10.1002/stem.2286
10.1002/stem.2286 · External reference
Predicting selective drug targets in cancer through metabolic networks
10.1038/msb.2011.35 · 2011 · External reference
10.1002/msb.145122
10.1002/msb.145122 · External reference
Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells
10.1371/journal.pcbi.1005914 · 2018 · External reference
10.3390/cancers13030425
10.3390/cancers13030425 · External reference
10.1002/ijc.2910260208
10.1002/ijc.2910260208 · External reference
10.1038/nature11005
10.1038/nature11005 · External reference
10.1038/nature11003
10.1038/nature11003 · External reference
10.1016/j.cell.2013.08.003
10.1016/j.cell.2013.08.003 · External reference
10.1038/cddis.2011.129
10.1038/cddis.2011.129 · External reference
Unresolved reference
External reference
10.1093/bioinformatics/bts635
10.1093/bioinformatics/bts635 · External reference
10.1186/s13059-014-0550-8
10.1186/s13059-014-0550-8 · External reference
10.1186/1752-0509-7-74
10.1186/1752-0509-7-74 · External reference
Recon 2.2: from reconstruction to model of human metabolism
10.1007/s11306-016-1051-4 · 2016 · External reference
10.1038/nbt.1614
10.1038/nbt.1614 · External reference
10.1093/bioinformatics/btt493
10.1093/bioinformatics/btt493 · External reference
10.1371/journal.pone.0086587
10.1371/journal.pone.0086587 · External reference
10.1073/pnas.232349399
10.1073/pnas.232349399 · External reference
10.1186/1471-2164-9-488
10.1186/1471-2164-9-488 · External reference
Thymidylate synthase inhibitors as anticancer agents: from bench to bedside
10.1007/s00280-003-0625-9 · 2003 · External reference
Dual inhibitors of thymidylate synthase and dihydrofolate reductase as antitumor agents: design, synthesis, and biological evaluation of classical and nonclassical pyrrolo[2,3-d]pyrimidine anti-folates (1)
10.1021/jm058276a · 2006 · External reference
Unresolved reference
External reference
Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance
10.1016/j.drup.2012.07.002 · 2012 · External reference
10.1038/sj.onc.1206946
10.1038/sj.onc.1206946 · External reference
10.1182/blood-2002-07-2283
10.1182/blood-2002-07-2283 · External reference
10.1038/sj.bjp.0705229
10.1038/sj.bjp.0705229 · External reference
10.1016/s1658-3876(08)50023-9
10.1016/s1658-3876(08)50023-9 · External reference
10.1002/9783527696130.ch5
10.1002/9783527696130.ch5 · External reference
Pharmacogenomic and clinical data link non-pharmacokinetic metabolic dysregulation to drug side effect pathogenesis
10.1038/ncomms8101 · 2015 · External reference
10.1371/journal.pcbi.1003580
10.1371/journal.pcbi.1003580 · External reference
The landscape of tiered regulation of breast cancer cell metabolism
10.1038/s41598-019-54221-y · 2019 · External reference
10.1038/s41375-019-0461-5
10.1038/s41375-019-0461-5 · External reference
10.1016/j.cell.2016.08.057
10.1016/j.cell.2016.08.057 · External reference
10.1038/s41467-018-03441-3
10.1038/s41467-018-03441-3 · External reference
Pharmacological inhibition of dihydroorotate dehydrogenase induces apoptosis and differentiation in acute myeloid leukemia cells
10.3324/haematol.2018.188185 · 2018 · External reference
10.1158/1535-7163.mct-18-0863
10.1158/1535-7163.mct-18-0863 · External reference
High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG
10.1038/leu.2017.283 · 2018 · External reference
10.1038/s41375-021-01189-2
10.1038/s41375-021-01189-2 · External reference
A possible role for Methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia
10.1016/s0959-8049(00)00433-0 · 2001 · External reference
Sequential administration of Methotrexate and asparaginase in relapsed or refractory pediatric acute myeloid leukemia
10.1002/pbc.24470 · 2013 · External reference
Understanding and managing methotrexate nephrotoxicity
10.1634/theoncologist.11-6-694 · 2006 · External reference
10.1016/s0145-2126(02)00085-1
10.1016/s0145-2126(02)00085-1 · External reference
10.1126/scitranslmed.aaq1240
10.1126/scitranslmed.aaq1240 · External reference
Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndrome
10.1002/ajh.23981 · 2015 · External reference
